活血化瘀注射液I号预处理与缺血预处理改善肝缺血再灌注损伤

表5 不同组肝组织MDA含量的变化(mean±SD, nmol/g)

分组	MDA				SOD
	1 h	3 h	6 h	24 h	1 h	3 h	6 h	24 h
Sham	7.32±0.53	7.58±0.62	7.50±0.60	7.47±0.73	182.50±13.10	181.70±10.20	183.70±10.20	185.5±7.89
I/R	13.80±1.19b	20.72±1.34b	28.70±2.29b	16.07±1.738b	144.10±8.03b	134.50±7.45b	110.80±9.82b	129.9±4.98b
IP	11.75±1.22bc	17.48±1.71bc	21.66±1.84bc	12.77±1.45bc	154.60±8.70b	140.90±6.35b	124.70±9.32bc	141.6±7.74bc
HHI-I	10.45±1.31bc	14.49±1.89bce	17.35±1.39bce	11.58±2.32bc	169.50±5.60ce	156.20±9.88bce	136.00±12.50bce	149.8±8.98bc

^bP<0.01 vs Sham组;

^cP<0.05 vs I/R组;

^eP<0.05 vs IP组.